Clinical Quiz: HCV DAA Treatment After Solid Organ Transplantation


This clinical quiz will test your knowledge of the 2023 American Association for the Study of Liver Diseases/Infectious Diseases Society of America Hepatitis C guideline.

Clinician and liver | Credit: Pixabay

Credit: Pixabay

Since 2013, the Infectious Diseases Society of America and the American Association for the Study of Liver Diseases have worked together to develop evidence-based guidance for the diagnosis, management, and treatment of hepatitis C virus (HCV) infection.

This update to the previous 2020 guidelines was released in 2023 and reflects our current understanding of the infection with timely, evidence-based guidance spotlighting major changes related to screening, organ transplantation, and expanded treatment options for children and adolescents.

Test your knowledge of the 2023 HCV guidance update below:

When should treatment be initiated for HCV-uninfected recipients of liver grafts from HCV-viremic donors using glecaprevir/pibrentasvir?


  1. Bhattacharya D, Aronsohn A, Price J, Lo Re V; AASLD-IDSA HCV Guidance Panel. Hepatitis C Guidance 2023 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection. Clin Infect Dis. Published online May 25, 2023. doi:10.1093/cid/ciad319

Editors' note: Artificial intelligence aided in the creation of this content.

Related Videos
Video 2 - "COPD Traits Associated with Phenotypes"
Video 1 - "Why is COPD Important?"
HCPLive Five at APA 2024 | Image Credit: HCPLive
Video 4 - "Moderate/Severe/Uncontrolled Asthma Classification"
Video 3 - "Type 2 Inflammation and Biomarkers in Asthma"
Video 6 - "Evaluating Safety of Novel LDL Management Mechanism"
Video 5 - "Optimizing PCSK9 Inhibitors and Analyzing Plaque Reduction Data"
© 2024 MJH Life Sciences

All rights reserved.